Month: September 2013

By Ben Hirschler LONDON (Reuters) – An experimental cancer vaccine from GlaxoSmithKline failed to help melanoma patients in a closely watched late-stage clinical trial, dealing a blow to the high-risk, high-reward project. Britain's biggest drugmaker said on Thursday that it would continue with the Phase III trial of its MAGE-A3 therapeutic vaccine to see if it benefited a subset of patients with a particular genetic signature. …

JOHANNESBURG (Reuters) – South Africa’s biggest generic drug maker Aspen Pharmacare said on Thursday talks with Britain’s GlaxoSmithKline about its $700 bid for drugs and a factory continues. Aspen offered to buy GSK’s thrombosis drug brands Arixtra and Fraxiparine, sales of which are in decline, along with a related French factory in June. (Reporting by Tiisetso Motsoeneng; editing by David Dolan)

By Keith Coffman DENVER (Reuters) – Football fans heading to the NFL season opener between the Baltimore Ravens and the Denver Broncos on Thursday will see a huge billboard urging the league to loosen its policy on marijuana use by players. The 14-by-48-foot (4.3-by-14.6-meter) sign along the main boulevard leading to Denver's Sports Authority Field at Mile High calls on the league to "Stop Driving Players to Drink – A Safer Choice is Now Legal (Here)," referring to Colorado's recent legalization of recreational marijuana. …

Some drinks can blow your daily calorie budget.        

Dr. Spyros Panos has surrendered his medical lisense and admitted to guilt in 7 of the cases against him.